Answer
Rapamune (sirolimus) is indicated to treat patients with sporadic lymphangioleiomyomatosis who have moderate lung disease or declining lung function.
Sources for this answer
- Rapamune 2 mg coated tabletsPfizer Limited · emc · SmPC §4.1 Therapeutic Indications · Version 54Document updated
Sources checked